The kinetics of controlled release of basic fibroblast growth factor (bFGF) from polymers (sutures, polycarbonate, Hydron, and Elvax), biopolymers (alginate), and biomatrices (lens capsules), and conditions for storage of bFGF (temperature, plastic type, heparin) were evaluated in vitro. Tissue culture proliferation bioassays with 3T3 fibroblasts, showed that only lens capsules with bFGF had a sustained release of bFGF for up to three weeks. The other materials released all of the `bound' bFGF with two hours or produced an inflammatory response in vivo. Therefore, the lens tissue had the most potential for controlled long-term delivery of bFGF in vivo. These studies emphasise the importance of in vitro analysis of release kinetics of growth factors from a range of materials as a basis for potential in vivo applications.
1. Gospodarowicz, D. and J. S. Moran. 1974. "Stimulation of Division of Sparse and Confluent 3T3 Cell Populations by a Fibroblast Growth Factor, Dexamethasone and Insulin,"Proc. Natl. Acad. Sci. USA, 71:4584-4588.
2.
2. Baird, A. and P. Bohlen. 1991. "Fibroblast Growth Factors," in Peptide Growth Factors and Their Receptors, M. B. Sporn and A. B. Roberts (eds.), New York: Springer-Verlag, pp. 369-418.
3.
3. Baird, A.1994. "Potential Mechanisms Regulating the Extracellular Activities of Basic Fibroblast Growth Factor (FGF-2),"Mol. Reprod. Dev., 39:43-48.
4.
4. Gonzalez, A.-M., M. Buscagalia, M. Ong and A. Baird. 1990. "Distribution of Basic Fibroblast Growth Factor in the 18-Day Rat Fetus: Localization in the Basement Membranes of Diverse Tissues,"J. Cell Biol., 110:753-765.
5.
5. Folkman, J., M. Klagsbrun, J. Sasse, M. Wadzinski, D. Ingber and I. Vlodavsky. 1988. "A Heparin Binding Angiogenic Protein-Basic Fibroblast Growth Factor is stored within basement membrane,"Am. J. Pathol., 130:393-400.
6.
6. Gospodarowicz, D.1990. "Fibroblast Growth Factor. Chemical and Biologic Function,"Clin. Orthopaed. Rel. Res., 257:231-248.
7.
7. Mitchell, C. A., J. M. McGeachie and M. D. Grounds. 1996. "Exogenous Administration of Basic FGF Does Not Enhance the Regeneration of Murine Skeletal Muscle,"Growth Factors, 13:1-19.
8.
8. Mitchell, C. A., M. J. Davies, J. K. McGeachie, M. D. Grounds, G. C. Crawford, Y. Hong and T. V. Chirila. 1996. "Enhanced Neovascularisation in Regenerating Skeletal Muscle by the Sustained Release of Erucamide from a Polymer Matrix,"J. Biomater. Appl., 10:230-249.
9.
9. Gospodarowicz, D. and J. Moran. 1975. "Optimal Conditions for the Study of Growth Control in BALB/c 3T3 Fibroblasts,"Exp. Cell Res., 90:279-284.
10.
10. Sullivan, R. and M. Klagsbrun. 1986. "Purification and Assay of Intact Human Basic Fibroblast Growth Factor Using Heparin-Sepharose Chromatography,"J. Tissue Culture Meth., 10:125-132.
11.
11. Edelman, E. R., D. H. Adams and M. J. Karnovsky. 1990. "Effect of Controlled Adventitial Heparin Delivery on Smooth Muscle Cell Proliferation Following Endothelial Injury,"Proc. Natl. Acad. Sci., USA, 87:3773-3777.
12.
12. Nugent, M. A., O. S. Chen and E. R. Edelman. 1992. "Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture,"Mat. Res. Soc. Symp. Proc., 252:273-284.
13.
13. Cohn, E. J., L. E. Strong, W. L. Hughes, D. J. Mulford, J. N. Ashworth, M. Melin and H. L. Taylor. 1946. "Preparation and Properties of Serum and Plasma Proteins, IV A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids,"J. of Am. Chem. Soc., 68:459-475.
14.
14. Leonard, M. and Hjelmeland. 1980. "A Nondenaturing Zwitterionic Detergent for Membrane Biochemistry: Design and Synthesis,"Proc. Natl. Acad. Sci., USA, 77:6368-6370.
15.
15. Shing, Y., J. Folkman, R. Sullivan, C. Butterfield, J. Murray and M. Klagsbrun. 1984. "Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor,"Science, 223:1296-1299.
16.
16. Gospodarowicz, D. and J. Cheng. 1986. "Heparin Protects Basic and Acidic FGF from Inactivation,"J. Cell. Physiol., 128:475-484.
17.
17. Saksela, O., D. Moscatelli, A. Sommer and D. B. Rifkin. 1988. "Endothelial Cell Derived Heparin Sulphate Binds Basic Fibroblast Growth Factor and Protects It from Proteolytic Degradation,"J. Cell Biol., 107:743-751.
18.
18. Flaumenhaft, R., D. Moscatelli and D. B. Rifkin. 1990. "Heparin and Heparin Sulfate Increase the Radius of Diffusion and Action of Basic Fibroblast Growth Factor,"J. Cell Biol., 111:1651-1659.
19.
19. Kan, M., F. Wang, J. Xu, J. W. Crabb, J. Hou and W. McKeehan. 1993. "An Essential Heparin Binding Domain in the Fibroblast Growth Factor Receptor Kinase,"Science, 259:1918-1921.
20.
20. Brickman, Y., M. D. Ford, D. H. Small, P. F. Bartlett and V. Nurcombe. 1995. "Heparin Sulphates Mediate the Binding of Basic Fibroblast Growth Factor to a Specific Receptor on Neural Precursor Cells,"J. Biol. Chem., 270:1-8.
21.
21. Korman, M. G., T. D. Bolin, S. Szabo, R. H. Hunt, I. N. Marks and H. Glise. 1994. "Sucralfate: The Bangkok Review,"J. Gastroenterol. Hepatol., 9:412-415.
22.
22. Harvey, A. R., M. Chen, G. W. Plant and S. E. Dyson. 1994. "Regrowth of Axons within Schwann Cell-Filled Polycarbonate Tubes Implanted into the Damaged Optic Tract and Cerebral Cortex of Rats."Restor. Neurol. Neurosci., 6:221-239.
23.
23. Lovicu, F. J. and J. W. McAvoy. 1993. "Localization of Acidic Fibroblast Growth Factor, Basic Fibroblast Growth Factor and Heparin Sulphate Proteoglycan in Rat Lens: Implications for Lens Polarity and Growth Patterns,"Invest. Ophthalol. Vis. Sci., 34:3355-3365.
24.
24. Halle, J. P., D. Landry, A. Fournier, M. Beaudry and F. A. Leblond. 1993. "Method for the Quantification of Alginate in Microcapsules,"Cell Transplant, 2:429-436.
25.
25. Edelman, E. R., E. Mathiowitz, R. Langer and M. Klagsbrun. 1991. "Controlled and Modulated Release of Basic Fibroblast Growth Factor,"Biomaterials, 12:619-626.
26.
26. Langer, R. and J. Folkman. 1976. "Polymers for the Sustained Release of Proteins and Other Macromolecules,"Nature, 263:797-800.
27.
27. Maley, M. A., M. V. Agrez and A. K. House. 1986. "Growth Factor-Induced Proliferative Responses of Human and DMH-Induced Rat Colorectal Tumour Cell Lines,"Aust. J. Exp. Biol. Med. Sci., 64:445-451.
28.
28. Parmigiani, C. M. and J. W. McAvoy. 1989. "A Morphometric Analysis of the Development of the Rat Lens Capsule,"Curr. Eye Res., 8:1271.
29.
29. Plant, G. W. and A. R. Harvey. 1994. "Polymer Bridges Containing Extracellular Matrix and Cultured Schwann Cells Implanted into the Lesioned Rat Optic Tract,"Proc., 5th Internat. Neurol. Transplant, p. 76.
30.
30. Chapman, V. J. and D. J. Chapman. 1980. "Algin and Alginates," in Seaweeds and Their Uses, in Chapman and Hall (ed.), London, pp. 194-225.
31.
31. Espevik, T., M. Otterlie, G. Skjak-Braek, A. Sundan and O. Smidsrod. 1992. "Immunological Aspects of Alginate Used for Microencapsulation,"1 st Intl. Congress Cell Transplant. Soc., Abstract, Number 126.
32.
32. Soon-Shiong, P., M. Otterlie, G. Skak-Braek, P. Smidsrod, R. Heintz, R. P. Lanza and T. Espevik. 1991. "An Immunologic Basis for the Fibrotic Reaction to Implanted Microcapsules,"Transplant. Proc., 23:758-759.
33.
33. de Vos., P., B. J. de Haan, G. H. J. Wolters and R. van Schilfgaarde. 1994. "Islets Protruding from Alginate-Polylysine Microcapsules Contributes to Bio-Incompatibility,"Cell Transplant Abstract, 3:106.
34.
34. Gospodarowicz, D. and J. Moran. 1974. "Effect of Fibroblast Growth Factor, Insulin, Dexamethasone, and Serum on the Morphology of BALB/c 3T3 Cells,"Proc. Natl. Acad. Sci., USA, 71:4648-4652.
35.
35. Plunkett, M. L. and J. A. Hailey. 1990. "Methods in Laboratory Investigation. An in vivo Quantitative Angiogenisis Model Using Tumour Cells Entrapped in Alginate,"Lab. Invest., 62:510-517.
